Improving T-Cell Assays for Diagnosis of Latent Tb Infection: Confirmation of the Potential Role of Testing Interleukin-2 Release in Iranian Patients

Improving T-Cell Assays for Diagnosis of Latent Tb Infection: Confirmation of the Potential Role of Testing Interleukin-2 Release in Iranian Patients Publisher Pubmed

Mamishi S^{1, 2} ; Pourakbari B¹ ; Shams H³ ; Marjani M⁴ ; Mahmoudi S¹

Show Affiliations

1. Pediatric Infectious Disease Research Center, Tehran University of Medical Science, Tehran, Iran
2. Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
3. Center for Pulmonary and Infectious Disease Control, and Departments of Microbiology and Immunology and Medicine, University of Texas Health Center at Tyler, Tyler, TX, United States
4. Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Allergologia et Immunopathologia Published:2016

Abstract

Background Since gamma interferon release assays (IGRAs) cannot differentiate between active tuberculosis and latent tuberculosis infection (LTBI), development of rapid and specific diagnosis tools are essential for discriminating between active tuberculosis (TB) from LTBI. Both IGRAs are based on Mycobacterium tuberculosis-specific antigens, namely, early secretory antigenic target 6 (ESAT-6) and 10 kDa culture filtrate (CFP-10). The aim of this study was to evaluate the potential value of IL-2 secretion by whole blood cells after stimulation with rESAT-6 and rCFP-10 for discriminating between active and latent tuberculosis. Methods Interleukin-2 and IFN-γ were measured after blood stimulation of 90 cases (30 with active TB, 30 with LTBI and 30 healthy controls) with recombinant ESAT-6 and CFP-10. Receiver operating characteristic (ROC) curve analysis was conducted to determine the best IL-2 and IFN-γ result thresholds in discriminating between cases with active or latent TB, and the corresponding sensitivity and specificity were recorded. Results The IFN-γ release assay demonstrated a good sensitivity and specificity (sensitivity 83–84% and specificity 92%) for diagnosis of tuberculosis. The discrimination performance of IL-2 assay (assessed by the area under ROC curve) between LTBI and patients with active TB were 0.75 and 0.8 following stimulation with rESAT-6 and rCFP-10, respectively. Maximum discrimination was reached at a cut-off of 11.6 pg/mL for IL-2 after stimulation with recombinant rESAT-6 with 72% sensitivity and 79% specificity and 10.7 pg/mL for IL-2 following stimulation with rCFP-10 with 75% sensitivity and 79% specificity, respectively. Conclusion This study demonstrates that rESAT-6 and rCFP-10 can provide a sensitive and specific diagnosis of TB. In addition, it was shown that IL-2 may be serving as a marker for discriminating LTBI and active TB. © 2015 SEICAP

Related Docs

View other Related Docs

1. Novel T-Cell Assays for the Discrimination of Active and Latent Tuberculosis Infection: The Diagnostic Value of Ppe Family, Molecular Diagnosis and Therapy (2015)

2. Diagnostic Accuracy of Interferon (Ifn)-Γ Inducible Protein 10 (Ip-10) As a Biomarker for the Discrimination of Active and Latent Tuberculosis, Molecular Biology Reports (2019)

3. Diagnostic Accuracy of Monocyte Chemotactic Protein (Mcp)-2 As Biomarker in Response to Pe35/Ppe68 Proteins: A Promising Diagnostic Method for the Discrimination of Active and Latent Tuberculosis, Protein and Peptide Letters (2019)

4. Interferon Gamma Release Assay in Response to Pe35/Ppe68 Proteins: A Promising Diagnostic Method for Diagnosis of Latent Tuberculosis, European Cytokine Network (2017)

5. Differential Gene Expression of Asun, Nemf, Ptprc and Dhx29: Candidate Biomarkers for the Diagnosis of Active and Latent Tuberculosis, Infectious Disorders - Drug Targets (2021)

6. Discriminating Between Latent and Active Tuberculosis: The Role of Interleukin-2 As Biomarker, Journal of Infection (2015)

7. Evaluation of Treatment Response in Active Tuberculosis Using Quantiferon-Tb Gold Plus, European Cytokine Network (2020)

8. Screening of Healthcare Workers for Latent Tuberculosis Infection in the Low Tuberculosis Burden Country: Quantiferon-Tb Gold in Tube Test or Tuberculin Skin Test?, Archives of Environmental and Occupational Health (2019)

Experts (# of related papers)

View all Related Experts

Shima Mahmoudi (15)

Setareh Mamishi Khanlagh (15)

Style	Citing Format
MLA	Mamishi S, et al.. "Improving T-Cell Assays for Diagnosis of Latent Tb Infection: Confirmation of the Potential Role of Testing Interleukin-2 Release in Iranian Patients." Allergologia et Immunopathologia, vol. 44, no. 4, 2016, pp. 314-321.
APA	Mamishi S, Pourakbari B, Shams H, Marjani M, Mahmoudi S (2016). Improving T-Cell Assays for Diagnosis of Latent Tb Infection: Confirmation of the Potential Role of Testing Interleukin-2 Release in Iranian Patients. Allergologia et Immunopathologia, 44(4), 314-321.
Chicago	Mamishi S, Pourakbari B, Shams H, Marjani M, Mahmoudi S. "Improving T-Cell Assays for Diagnosis of Latent Tb Infection: Confirmation of the Potential Role of Testing Interleukin-2 Release in Iranian Patients." Allergologia et Immunopathologia 44, no. 4 (2016): 314-321.
Harvard	Mamishi S et al. (2016) 'Improving T-Cell Assays for Diagnosis of Latent Tb Infection: Confirmation of the Potential Role of Testing Interleukin-2 Release in Iranian Patients', Allergologia et Immunopathologia, 44(4), pp. 314-321.
Vancouver	Mamishi S, Pourakbari B, Shams H, Marjani M, Mahmoudi S. Improving T-Cell Assays for Diagnosis of Latent Tb Infection: Confirmation of the Potential Role of Testing Interleukin-2 Release in Iranian Patients. Allergologia et Immunopathologia. 2016;44(4):314-321.
BibTex	@article{ author = {Mamishi S and Pourakbari B and Shams H and Marjani M and Mahmoudi S}, title = {Improving T-Cell Assays for Diagnosis of Latent Tb Infection: Confirmation of the Potential Role of Testing Interleukin-2 Release in Iranian Patients}, journal = {Allergologia et Immunopathologia}, volume = {44}, number = {4}, pages = {314-321}, year = {2016} }
RIS	TY - JOUR AU - Mamishi S AU - Pourakbari B AU - Shams H AU - Marjani M AU - Mahmoudi S TI - Improving T-Cell Assays for Diagnosis of Latent Tb Infection: Confirmation of the Potential Role of Testing Interleukin-2 Release in Iranian Patients JO - Allergologia et Immunopathologia VL - 44 IS - 4 SP - 314 EP - 321 PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract